, Tracking Stock Market Picks
Enter Symbol:
Anthera Pharmaceuticals, Inc. (ANTH) [hlAlert]

down 70.50 %

Anthera Pharmaceuticals, Inc. (ANTH) rated Buy with price target $6 by Canaccord Genuity

Posted on: Monday,  Mar 12, 2012  9:25 AM ET by Canaccord Genuity

Canaccord Genuity rated Buy Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) on 03/12/2012, when the stock price was $25.60. Since
then, Anthera Pharmaceuticals, Inc. has lost 70.51% as of 01/13/2016's recent price of $7.55.
If you would have followed this Canaccord Genuity's recommendation on ANTH, you would have lost 70.5% of your investment in 1402 days.

Anthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on developing and commercializing therapeutics to treat diseases associated with inflammation, including cardiovascular and autoimmune diseases. Its primary product candidates include varespladib methyl (A-002), which has completed its Phase 2 clinical studies for the treatment of acute coronary syndrome; varespladib sodium (A-001) that is in a Phase 2 clinical study for the prevention of acute chest syndrome associated with sickle cell disease; and A-623, which has completed Phase 1 clinical studies for the treatment of B-cell mediated autoimmune diseases. The company has license agreements with Eli Lilly and Company, and Shionogi & Co., Ltd. to develop and commercialize secretory phospholipase A2 or sPLA2 inhibitors for the treatment of cardiovascular disease and other diseases; and Amgen Inc., to develop and commercialize A-623. Anthera Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Hayward, California.

Canaccord Genuity’s global team of over 100 research professionals are inquisitive, experienced and committed to generating actionable investment ideas. We analyze over 725 companies in a broad range of market sectors, identifying value and defining risk for our clients.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/12/2012 9:25 AM Buy
25.60 48.00
as of 12/31/2012
1 Week down  -3.12 %
1 Month down  -3.12 %
3 Months down  -37.37 %
1 YTD down  -80.62 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy